Noxxon Announces Issuance of Tranches of Convertible Bonds Under Financing Agreement With Atlas
The investor, Atlas Special Opportunities, LLC, has received 967 Convertible Bonds (including 17 Convertible Bonds issued in relation to the transaction fee) with a nominal value of 1,000 each.
- The investor, Atlas Special Opportunities, LLC, has received 967 Convertible Bonds (including 17 Convertible Bonds issued in relation to the transaction fee) with a nominal value of 1,000 each.
- NOXXON maintains an updated summary table of issued convertible bonds in the Investors section of its website.
- The characteristics, terms, conditions and dilutive potential of the financing may be found in the Annex to the press release published on April 23, 2020 available on the companys website.
- NOXXON plans to test NOXE36 in patients with solid tumors both as a monotherapy and in combination.